Telix IsoTherapeutics

Telix IsoTherapeutics, formerly known as IsoTherapeutics Group, is a specialized radiopharmaceutical company based in Angleton, Texas, that provides comprehensive drug development, manufacturing, and analytical services. Acquired by Telix Pharmaceuticals in 2024, the entity serves as a core research and manufacturing hub, particularly focusing on the development of radiolabeled compounds for oncology. The company offers expertise in isotope processing, bioconjugation, and GMP manufacturing to support both internal Telix programs and external partners. Its facilities are equipped to handle a wide range of radioisotopes for both diagnostic and therapeutic applications, significantly enhancing Telix's vertically integrated supply chain in North America.